Emil Andersson
Overview
Explore the profile of Emil Andersson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
65
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Andersson E, Keranen A, Lagerstedt-Robinson K, Ghazi S, Lindblom A, Tham E, et al.
Hered Cancer Clin Pract
. 2024 Aug;
22(1):14.
PMID: 39175077
Background: The aim of the study was to test a universal screening strategy on endometrial cancer to evaluate its effectiveness to find Lynch Syndrome (LS) cases to two established clinical...
2.
Andersson E, Hult J, Troein C, Stridh M, Sjogren B, Pekar-Lukacs A, et al.
iScience
. 2024 Apr;
27(5):109653.
PMID: 38680659
In the dawning era of artificial intelligence (AI), health care stands to undergo a significant transformation with the increasing digitalization of patient data. Digital imaging, in particular, will serve as...
3.
Andersson E, Rothenberg E, Peterson C, Olariu V
NPJ Syst Biol Appl
. 2024 Apr;
10(1):40.
PMID: 38632273
T-cell development provides an excellent model system for studying lineage commitment from a multipotent progenitor. The intrathymic development process has been thoroughly studied. The molecular circuitry controlling it has been...
4.
Lohr J, Ohlund D, Soreskog E, Andersson E, Vujasinovic M, Zethraeus N, et al.
Fam Cancer
. 2024 Mar;
23(3):399-403.
PMID: 38441833
Screening of the general population for cancer is a matter of primary prevention reducing the burden of disease. Whilst this is successful for several cancers including breast, colon and prostate,...
5.
Andersson E, Rothenberg E, Peterson C, Olariu V
bioRxiv
. 2023 Oct;
PMID: 37905091
T-cell development provides an excellent model system for studying lineage commitment from a multipotent progenitor. The intrathymic development process has been thoroughly studied. The molecular circuitry controlling it has been...
6.
Govorov I, Attarha S, Kovalevska L, Andersson E, Kashuba E, Mints M
Sci Rep
. 2022 Dec;
12(1):22154.
PMID: 36550267
In a previous study, we showed that serine/threonine-protein kinase 4 (STK4) is involved in the control on proliferation and migration of endometrial cancer (EC) cells in vitro. In the present...
7.
Andersson E, Sjo M, Kaji K, Olariu V
iScience
. 2022 Aug;
25(8):104743.
PMID: 35942105
Experimental and computational efforts are constantly made to elucidate mechanisms controlling cell fate decisions during development and reprogramming. One powerful computational method is to consider cell commitment and reprogramming as...
8.
Govorov I, Attarha S, Kovalevska L, Andersson E, Kashuba E, Mints M
Cancer Control
. 2022 May;
29:10732748221094797.
PMID: 35533253
Background: Several markers of survival among endometrial cancer (EC) patients have been proposed, namely, the oncoprotein stathmin, RAF kinase inhibitor (RKIP), Cyclin A, GATA-binding protein 3 (GATA3), and growth and...
9.
Kanstrup M, Rudman A, Goransson K, Andersson E, Olofsdotter Lauri K, Rapoport E, et al.
Pilot Feasibility Stud
. 2021 Oct;
7(1):184.
PMID: 34620249
Background: The current study explored how to recruit patients soon after a traumatic event, to deliver a novel intervention in a new emergency department in Sweden. This brief behavioral intervention...
10.
Olariu V, Yui M, Krupinski P, Zhou W, Deichmann J, Andersson E, et al.
Cell Rep
. 2021 Jan;
34(2):108622.
PMID: 33440162
Intrathymic development of committed progenitor (pro)-T cells from multipotent hematopoietic precursors offers an opportunity to dissect the molecular circuitry establishing cell identity in response to environmental signals. This transition encompasses...